About
Mr. Arpesh Mehta served as a Senior Research Associate of Ceregene. Mr. Mehta is playing an integral role in the development and IND submission for an Alzheimer’s disease therapeutic, and worked on the preclinical development of a gene therapy product in clinical trials. Mr. Mehta worked on numerous investments in the clean technology and biotechnology sectors, being involved with all stages of the investment process from evaluating investment prospects to board governance. Mr. Mehta's cleantech investment involvement includes Virent, EcoSynthetix, Aspectrics (acquired by Guided Wave), BrightSource Energy, and Sindicatum Renewable Resources. Prior to Black River, Mr. Mehta held various R&D and marketing positions in the biotech industry. He worked as a staff researcher at the Geffen School of Medicine at UCLA, where he published numerous papers on the characterization of potential drug targets and has presented his research at international conferences. In addition, Mr. Mehta was a
Position in the VCSift Database
- • 2 investors at DSM Venturing are tracked.
- • 165 investors hold the Investment Director role in VCSift. Arpesh Mehta is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Arpesh
Search Investors